Punishing brand ambassadors shows that the government is only interested in going after the low hanging fruit, says Tanmaya Nanda.
The broader markets ended negatively with mid-caps and small-caps shedding 0.5 per cent on the BSE.
A huge stock of Maggi noodles was destroyed by Nestle after the ban was imposed by the food regulators.
The company spokesperson expressed disappointment with the "unprecedented step of filing of a complaint before the NCDRC"
The 50-share NSE Nifty stayed in the positive zone and retook the 9,900-mark to hit a high of 9,905.05 as buying paced up towards the fag end. It settled higher by 72.45 points, or 0.74 per cent, at 9,899.60.
In the Sensex pack, ICICI Bank emerged as the top gainer by rising 0.97 per cent, while Tata Steel advanced 0.92 per cent.
It hopes to turn around Ranbaxy within four years of closing the deal by improving efficiency and resolving all regulatory issues
The recalled drug bottles were distributed by Caraco Pharmaceutical Laboratories, Ltd in the US while manufactured in India by Sun Pharmaceutical Industries Ltd.
Nestle now has less than two weeks to convince the regulator why product approval for its noodles should not be withdrawn
Its Waluj manufacturing facility in Maharashtra failed to meet the good manufacturing norms prescribed by the UK drug regulator.
Amneal Pharmaceuticals is set to pip Sun Pharma as the fifth largest generics maker in the US, reports Sohini Das.
Lack of clarity on whether manufacturing bans in Punjab, Uttarakhand, Himachal, Goa and Karnataka still in place
While the US health regulator did not specify details for issuing the alert, it said 'detention without physical examination may be appropriate when an FDA inspection has revealed that a firm is not operating in conformity with current good manufacturing practices'.
'The mismatch between valuations and fundamentals is startling,' warns Devangshu Datta
It was a disturbing message in the sense that the regulatory framework is not clear enough and is not always applied in a convincing manner.
In India, thousands of lives are lost every year because of unavailability of organs
Competition in the US pharmaceutical market swelled in recent years, with increasing generic penetration.
IT, pharma and FMCG stocks are the top performers in 2013.
DRL launched four new products in North America during the previous quarter.
Sun Pharma profit down 30% over compliance costs, lower sales.
4 Ranbaxy facilities in India have been barred from exporting to US.
.jpg)
The report comes at a time when the government is trying to clear pending FDI proposals, which include various planned investments in this sector.
In a surprise announcement in April, Sun and Ranbaxy -- at that time owned by Japan's Daiichi -- declared an all-stock deal to create India's largest and world's fifth-largest drugmaker in an over $4 billion deal.
'India easily remains one among the more attractive large economies, with high growth and stable/improving macros, as a top investment destination.' 'We are looking pretty good.'
Details on prices sought as 10 generic drugs become up to 83 times costlier in 6 months
Nestle on Monday started a market rollout of Maggi noodles.
market, was today seized from an illegal drug manufacturing unit in Jalgaon district in north Maharashtra and six persons were arrested, Directorate of Revenue Intelligence officials said.
Rate sensitive sectors were among the top gainers with Tata Motors and ICICI Bank leading the gains on the Sensex.
.jpg)
Markets ended flat on Tuesday, amid a volatile trading session, as investors exercised caution ahead of the two-day FOMC meet starting today and Reserve Bank of India's monetary policy later this week.
Maggi re-entered the market on November 9.
Sun Pharma's offer was tempting because Ranbaxy was too busy fighting fires in the US to concentrate on operations.
A day after getting a show-cause notice from the Indian regulator, senior executives from Ranbaxy Laboratories approached the drug controller's office on Tuesday afternoon, it was learnt.
According to Munjal, there is an opportunity for somebody who comes from a not for profit background in health care to do something.
On October 16, Nestl received the go-ahead to resume manufacturing Maggi.
Conor McGregor said on Tuesday he was retiring from the sport, five months after losing to Khabib Nurmagomedov in a controversial title fight
Aneesh Phadnis and Veena Mani find out what the manufacturers and the hospitals have to say.
The S&P BSE Sensex closed 318 points at 24,455 and the Nifty50 shed 99 points to end at 7,438.
The joint entity will have a market share of nine per cent in India. Analysts tracking the company said one of the key outcomes of the merger would be to create a single brand entity of Sun and the Ranbaxy brand would eventually dissolve.
On October 2, a legislature committee wrote letters to the 14 companies, initiating an investigation and seeking details about recent price increases in several generic products available in the American market.
The trouble for Nestle's Maggi started in Uttar Pradesh last month and has now spread nationwide. The Food and Drug Administration has directed all states on Wednesday to get sample of India's most popular instant noodles tested for high content of lead and mono-sodium glutamate, a taste enhancer.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances